HUM HUMANA INC

NYSE humana.com


$ 261.55 $ -3.60 (-1.36 %)    

Tuesday, 14-Oct-2025 12:23:59 EDT
QQQ $ 600.51 $ 5.29 (0.89 %)
DIA $ 462.89 $ 5.88 (1.29 %)
SPY $ 663.48 $ 6.19 (0.94 %)
TLT $ 90.54 $ -0.10 (-0.11 %)
GLD $ 379.91 $ 1.61 (0.43 %)
$ 271
$ 266.12
$ 261.50 x 46
$ 262.23 x 2
$ 258.00 - $ 267.57
$ 206.15 - $ 314.25
1,671,970
na
32.59B
$ 0.45
$ 20.68
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 04-30-2025 03-31-2025 10-Q
3 02-20-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 04-24-2024 03-31-2024 10-Q
7 02-15-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 04-26-2023 03-31-2023 10-Q
11 02-16-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 07-27-2022 06-30-2022 10-Q
14 04-27-2022 03-31-2022 10-Q
15 02-17-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 07-28-2021 06-30-2021 10-Q
18 04-28-2021 03-31-2021 10-Q
19 02-18-2021 12-31-2020 10-K
20 11-03-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 04-29-2020 03-31-2020 10-Q
23 02-20-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-16-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 02-17-2017 12-31-2016 10-K
36 11-04-2016 09-30-2016 10-Q
37 08-03-2016 06-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 02-18-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 humana-loses-second-lawsuit-to-reverse-medicare-bonus-cuts--bloomberg

https://www.bloomberg.com/news/articles/2025-10-14/humana-loses-second-lawsuit-to-reverse-medicare-bonus-cuts

 b-of-a-securities-maintains-neutral-on-humana-raises-price-target-to-300

B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $280 t...

 mizuho-maintains-outperform-on-humana-raises-price-target-to-345

Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $300 to $345.

 wells-fargo-maintains-overweight-on-humana-raises-price-target-to-347

Wells Fargo analyst Stephen Baxter maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $344 to $347.

 sp-500-nasdaq-100-dow-russell-2000-all-soar-to-record-highs-whats-moving-markets-friday

Another historic session is unfolding on Wall Street, where every major index surged to new records by midday trading on Friday...

 guggenheim-reiterates-buy-on-humanato-buy

Guggenheim analyst Jason Cassorla reiterates Humana (NYSE:HUM) from Buy to Buy.

 barclays-maintains-equal-weight-on-humana-lowers-price-target-to-245

Barclays analyst Andrew Mok maintains Humana (NYSE:HUM) with a Equal-Weight and lowers the price target from $315 to $245.

 nvidias-value-reaches-46-trillion-bitcoin-eyes-120000-whats-moving-markets-thursday

On the second day of the U.S. government shutdown, Wall Street remains largely subdued, with indexes showing only slight midday...

 humana-says-executing-on-ma-contract-diversification-strategy-starting-with-2026-annual-election-period-starting-on-oct-15-continues-to-anticipate-return-to-top-quartile-results-for-2027-ma-star-ratings-continues-to-expect-to-double-individual-ma-pre-tax--margin-in-2026-members-expected-to-be-enrolled-in-4-stars--above-contracts-in-2027-meaningfully-higher-than-about-20

- SEC Filing

 humana-says-has-14-of-members-in-45-star-plans-in-2026-based-on-preliminary-2026-medicare-advantage-star-ratings-data-co-has-12m-members-in-4-star--above-plans-for-2026-it-is-not-satisfied-with-its-2026-star-ratings-affirms-fy25-eps-guidance-of-1377-adjusted-fy-eps-of-17

Supplementary Audio Commentary Supplementary audio commentary from Humana's President and Chief Executive Officer, Jim Rech...

 tailorcare-expands-humana-medicare-advantage-partnership-to-dallas-and-denver-offering-personalized-msk-navigation-and-care-coordination-support

TailorCare, a leading provider of value-based specialty care solutions for musculoskeletal (MSK) health, today announced plans ...

 evercore-isi-group-initiates-coverage-on-humana-with-in-line-rating-announces-price-target-of-295

Evercore ISI Group analyst Elizabeth Suzuki initiates coverage on Humana (NYSE:HUM) with a In-Line rating and announces Pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION